| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 548 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 511 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 510 | 2024 |
| A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin S Fuloria, J Mehta, A Chandel, M Sekar, NNIM Rani, MY Begum, ... Frontiers in Pharmacology 13, 820806, 2022 | 314 | 2022 |
| Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy V Subramaniyan, S Chakravarthi, R Jegasothy, WY Seng, NK Fuloria, ... Toxicology reports 8, 376-385, 2021 | 130 | 2021 |
| Promising natural products in new drug design, development, and therapy for skin disorders: An overview of scientific evidence and understanding their mechanism of action NA Mohd Zaid, M Sekar, SR Bonam, SH Gan, PT Lum, MY Begum, ... Drug design, development and therapy, 23-66, 2023 | 105 | 2023 |
| Significance of chemically derivatized starch as drug carrier in developing novel drug delivery devices MK Malik, P Bhatt, T Kumar, J Singh, V Kumar, A Faruk, S Fuloria, ... The Natural Products Journal 13 (6), 40-53, 2023 | 104 | 2023 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 98 | 2024 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The lancet 403 (10440), 2057-2099, 2024 | 97 | 2024 |
| Ultraflexible liposome nanocargo as a dermal and transdermal drug delivery system K Sudhakar, S Fuloria, V Subramaniyan, KV Sathasivam, AK Azad, ... Nanomaterials 11 (10), 2557, 2021 | 95 | 2021 |
| A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer V Subramaniyan, S Fuloria, G Gupta, DH Kumar, M Sekar, KV Sathasivam, ... Chemico-biological interactions 351, 109735, 2022 | 93 | 2022 |
| Unveiling the connection: long-chain non-coding RNAs and critical signaling pathways in breast cancer R Thapa, O Afzal, G Gupta, AA Bhat, WH Almalki, SI Alzarea, I Kazmi, ... Pathology-Research and Practice 249, 154736, 2023 | 92 | 2023 |
| Drug delivery of natural products through nanocarriers for effective breast cancer therapy: A comprehensive review of literature KM Yap, M Sekar, S Fuloria, YS Wu, SH Gan, NNI Mat Rani, ... International Journal of Nanomedicine, 7891-7941, 2021 | 91 | 2021 |
| Blastocystis sp., parasite associated with gastrointestinal disorders: an overview of its pathogenesis, immune modulation and therapeutic strategies V Kumarasamy, D Anbazhagan, V Subramaniyan, S Vellasamy Current pharmaceutical design 24 (27), 3172-3175, 2018 | 89 | 2018 |
| Mangifera indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action KM Yap, M Sekar, LJ Seow, SH Gan, SR Bonam, NNI Mat Rani, PT Lum, ... Breast Cancer: Targets and Therapy, 471-503, 2021 | 88 | 2021 |
| Plasma modification techniques for natural polymer-based drug delivery systems P Bhatt, V Kumar, V Subramaniyan, K Nagarajan, M Sekar, SV Chinni, ... Pharmaceutics 15 (8), 2066, 2023 | 86 | 2023 |
| Hesperidin and its aglycone hesperetin in breast cancer therapy: A review of recent developments and future prospects KM Yap, M Sekar, YS Wu, SH Gan, NNIM Rani, LJ Seow, ... Saudi Journal of Biological Sciences 28 (12), 6730-6747, 2021 | 85 | 2021 |
| Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes S Nirenjen, J Narayanan, T Tamilanban, V Subramaniyan, V Chitra, ... Frontiers in immunology 14, 1216321, 2023 | 82 | 2023 |
| In silico molecular docking analysis of karanjin against alzheimer’s and parkinson’s diseases as a potential natural lead molecule for new drug design, development and therapy C Gnanaraj, M Sekar, S Fuloria, SS Swain, SH Gan, K Chidambaram, ... Molecules 27 (9), 2834, 2022 | 79 | 2022 |
| Evaluation of antitumor efficacy of chitosan-tamarind gum polysaccharide polyelectrolyte complex stabilized nanoparticles of simvastatin R Malviya, S Raj, S Fuloria, V Subramaniyan, K Sathasivam, U Kumari, ... International journal of nanomedicine, 2533-2553, 2021 | 78 | 2021 |
Dr. Shivkanya FuloriaAIMST UNIVERSITY, MALAYSIADirección de correo verificada de aimst.edu.my
